Surface modification of PLGA nanoparticles using chitosan: Effect of molecular weight, concentration, and degree of deacetylation

被引:32
作者
Al-Nemrawi, Nusaiba K. [1 ]
Okour, Arren R. [1 ]
Dave, Rutesh H. [2 ]
机构
[1] Jordan Univ Sci & Technol, Dept Pharmaceut Technol, Fac Pharm, Irbid, Jordan
[2] Long Isl Univ, Pharmaceut Sci, Brooklyn, NY USA
关键词
chitosan; mucoadhesive; poly (lactic-co-glycolic acid); MUCOADHESIVE PROPERTIES; DELIVERY; CALCITONIN;
D O I
10.1002/adv.22077
中图分类号
TQ [化学工业];
学科分类号
081705 [工业催化];
摘要
Poly (lactic-co-glycolic acid) (PLGA) is used to prepare biocompatible and biodegradable nanoparticles (NPs). Unfortunately, PLGA NPs suffer from certain limitations such as short residence time when applied on mucosal tissues. Coating PLGA NPs surfaces with chitosan can improve their mucoadhesiveness and enhance the residence time. In this study, two molecular weights of chitosan (60 and 15 kDa) and three degrees of deacetylations (DDA) (92%, 75% and 55%) were used to study the effect of the molecular weight, concentration, and DDA of chitosan on the properties (size, PDI, charge, and mucoadhesion) of PLGA NPs. The results showed that the size of the NPs increases with increase in the concentration or molecular weight of chitosan but decreases with increase in the DDA. Also, coating PLGA NPs with chitosan give them a positive charge that increases as the chitosan concentration, DDA, or molecular weight increase. In general, all formulations with chitosan-coated PLGA NPs had enhanced mucoadhesion, and this mucoadhesion improved as the chitosan concentration, DDA, or molecular weight increased.
引用
收藏
页码:3066 / 3075
页数:10
相关论文
共 43 条
[1]
Recent advances on chitosan-based micro- and nanoparticles in drug delivery [J].
Agnihotri, SA ;
Mallikarjuna, NN ;
Aminabhavi, TM .
JOURNAL OF CONTROLLED RELEASE, 2004, 100 (01) :5-28
[2]
Al-Nemrawi N. K., 2015, J PHARM SCI PHARM, V2, P1
[3]
Formulation and characterization of acetaminophen nanoparticles in orally disintegrating films [J].
Al-Nemrawi, Nusaiba K. ;
Dave, Rutesh H. .
DRUG DELIVERY, 2016, 23 (02) :540-549
[4]
Technical aspects of preparing PEG-PLGA nanoparticles as carrier for chemotherapeutic agents by nanoprecipitation method [J].
Almoustafa, Hassan A. ;
Alshawsh, Mohammed A. ;
Chik, Zamri .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 533 (01) :275-284
[5]
Development of hematin conjugated PLGA nanoparticle for selective cancer targeting [J].
Amin, Md. Lutful ;
Kim, Dami ;
Kim, SeJin .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 91 :138-143
[6]
Mucin structure, aggregation, physiological functions and biomedical applications [J].
Bansil, Rama ;
Turner, Bradley S. .
CURRENT OPINION IN COLLOID & INTERFACE SCIENCE, 2006, 11 (2-3) :164-170
[7]
Enhanced cellular association of paclitaxel delivered in chitosan-PLGA particles [J].
Chakravarthi, Sudhir S. ;
Robinson, Dennis H. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2011, 409 (1-2) :111-120
[8]
Chitosan nanoparticles as new ocular drug delivery systems:: in vitro stability, in vivo fate, and cellular toxicity [J].
de Campos, AM ;
Diebold, Y ;
Carvalho, ELS ;
Sánchez, A ;
Alonso, MJ .
PHARMACEUTICAL RESEARCH, 2004, 21 (05) :803-810
[9]
Formulation and characterization of an oily-based system for oral delivery of insulin [J].
Elsayed, Amani ;
Al Remawi, Mayyas ;
Qinna, Nidal ;
Farouk, Asim ;
Badwan, Adnan .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2009, 73 (02) :269-279
[10]
Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique [J].
Fan, Wen ;
Yan, Wei ;
Xu, Zushun ;
Ni, Hong .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2012, 90 :21-27